GLP2-TRZ 30mg
$129.99
- GLP2-TRZ 30mg dual incretin receptor agonist peptide for laboratory research.
- Supplied as lyophilized powder for studies involving GLP-1/GIP receptor signaling, glucose homeostasis mechanisms, metabolic pathway analysis, and incretin pharmacology research.
- Unit Size: 30mg (lyophilized powder, single vial)
- Type: Dual incretin receptor agonist peptide
- Molecular Weight: ~4813.46 g/mol
- Form: Lyophilized peptide powder
- Use: For in vitro laboratory research only
In stock
Description
GLP2-TRZ| 30mg | Dual Incretin Receptor Research Peptide
Description
GLP2-TRZ is a synthetic peptide studied in laboratory research for its dual agonist activity at both glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) receptors. These receptors are part of the incretin hormone system involved in metabolic regulation and glucose-dependent insulin signaling.
In controlled experimental models, GLP2-TRZ is investigated for its interaction with incretin signaling pathways and its ability to activate both GLP-1 and GIP receptor mechanisms simultaneously. This dual receptor engagement allows researchers to examine complex metabolic signaling networks, appetite-regulation pathways, and endocrine responses in laboratory environments.
Because of its dual agonist structure and extended peptide sequence, GLP2-TRZ is frequently used in research focused on glucose homeostasis mechanisms, incretin receptor pharmacology, and metabolic pathway regulation in experimental systems.
This vial contains 30mg of lyophilized GLP2-TRZ peptide intended strictly for controlled in vitro laboratory research applications.
Specifications
- Compound: GLP2-TRZ
- Unit Size: 30mg (lyophilized powder, single vial)
- Molecular Formula: C225H348N48O68
- Molecular Weight: ~4813.46 g/mol
- Form: Lyophilized peptide powder
- Solubility: Soluble in sterile or bacteriostatic water according to laboratory protocols
- Storage (lyophilized): Store in a cool, dry environment protected from light and moisture
- Storage (reconstituted): Refrigerate between 2–8 °C according to laboratory protocol
Research Applications
Dual Incretin Receptor Signaling Research
GLP2-TRZ is widely used in laboratory studies examining simultaneous activation of GLP-1 and GIP receptor pathways. Researchers investigate how dual incretin receptor engagement influences metabolic signaling networks in controlled experimental systems.
Glucose Homeostasis Research
Experimental models frequently utilize GLP2-TRZ to study mechanisms involved in glucose regulation and insulin signaling pathways associated with incretin hormone activity.
Metabolic Pathway Research
Researchers commonly study GLP2-TRZ in metabolic pathway investigations exploring energy balance, nutrient signaling, and endocrine regulatory mechanisms.
Incretin Pharmacology Research
The peptide is often used in receptor-binding and pharmacological research examining how dual incretin receptor agonists interact with cellular signaling pathways compared with single receptor agonists.
Appetite and Energy Regulation Research
Laboratory models may utilize GLP2-TRZ to examine hormonal signaling pathways associated with appetite regulation and energy balance mechanisms in metabolic research systems.
Intended Use
in vitro laboratory research use only
Legal Disclaimer
This product has not been evaluated by the U.S. Food and Drug Administration. No claims are made regarding the treatment, diagnosis, cure, or prevention of any disease. All information provided is intended strictly for scientific and educational purposes only.
Terms of Sale
All sales are final




